Navigation Links
Pregnancy not turning minds to mush: Study
Date:10/10/2008

mother rats.

"Rodent data shows that mother rats have improved multi-skilling capacity and less fear responses than non-mothers. The rat data suggests that mother rats navigate mazes more efficiently, have less anxiety and fear and excel at multi-skilling. That sounds to me like almost every mother I know and I hope that the human effects eventually mirror those findings," she said.


'/>"/>

Contact: Martyn Pearce
Martyn.Pearce@anu.edu.au
61-261-255-575
Research Australia
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Study identifies warning signs of pregnancy danger
2. Drug could improve pregnancy outcomes in wider range of women with insulin resistance
3. Low vitamin D during pregnancy linked to pre-eclampsia
4. Life on Mars pregnancy test successfully launched
5. Herpes virus link to complications in pregnancy
6. Exercise during pregnancy leads to a healthier heart in moms- and babies-to-be
7. Pregnancy is possible after cancer treatment
8. A new gene trigger for pregnancy disorder identified
9. A new analysis method allows to find out the sex of the baby from the second month of pregnancy
10. Diet prior to pregnancy determines sheeps gender
11. National Zoo giant panda pregnancy update
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Dip ordinary paper into ink infused with nanotubes and nanowires to create an instant battery 2Surety Leads Web Symposium to Address Data Integrity Issues in Bio-Sciences Industry 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 2ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 3ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 4